Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 22 February 2005
Vol. 2005, Issue 272, p. pe7
[DOI: 10.1126/stke.2722005pe7]

PERSPECTIVES

TRAF2: A Double-Edged Sword?

Zong-Ping Xia and Zhijian J. Chen*

Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390–9148, USA.

Summary: Ubiquitination is best known for its role in targeting proteins for degradation by the proteasome, but evidence of the nonproteolytic functions of ubiquitin is also rapidly accumulating. One example of the regulatory, rather than proteolytic, function of ubiquitin is provided by study of the tumor necrosis factor (TNF) receptor–associated factor (TRAF) proteins, which function as ubiquitin ligases to synthesize lysine 63 (K63)–linked polyubiquitin chains to mediate protein kinase activation through a proteasome-independent mechanism. Some TRAF proteins, such as TRAF2 and TRAF3, have recently been shown to have a positive role in the canonical pathway that activates nuclear factor {kappa}B (NF-{kappa}B) through I{kappa}B kinase ß (IKKß), but a negative role in the noncanonical pathway that activates NF-{kappa}B through IKK{alpha}. These opposing roles of TRAF proteins may be linked to their ability to synthesize distinct forms of polyubiquitin chains. Indeed, the TRAF2-interacting protein RIP can mediate IKK activation when it is modified by K63 polyubiquitin chains, but is targeted to degradation by the proteasome when it is K48-polyubiquitinted by the NF-{kappa}B inhibitor A20. Thus, ubiquitin chains are dynamic switches that can influence signaling outputs in dramatically different ways.

*Corresponding author. E-mail: zhijian.chen{at}utsouthwestern.edu

Citation: Z.-P. Xia, Z. J. Chen, TRAF2: A Double-Edged Sword? Sci. STKE 2005, pe7 (2005).

Read the Full Text

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
AIMP2 promotes TNF{alpha}-dependent apoptosis via ubiquitin-mediated degradation of TRAF2.
J. W. Choi, D. G. Kim, M. C. Park, J. Y. Um, J. M. Han, S. G. Park, E.-C. Choi, and S. Kim (2009)
J. Cell Sci. 122, 2710-2715
   Abstract »    Full Text »    PDF »
Growth Inhibition and Radiosensitization of Glioblastoma and Lung Cancer Cells by Small Interfering RNA Silencing of Tumor Necrosis Factor Receptor-Associated Factor 2.
M. Zheng, S. E. Morgan-Lappe, J. Yang, K. M. Bockbrader, D. Pamarthy, D. Thomas, S. W. Fesik, and Y. Sun (2008)
Cancer Res. 68, 7570-7578
   Abstract »    Full Text »    PDF »
Essential Cytoplasmic Translocation of a Cytokine Receptor-Assembled Signaling Complex.
A. Matsuzawa, P.-H. Tseng, S. Vallabhapurapu, J.-L. Luo, W. Zhang, H. Wang, D. A. A. Vignali, E. Gallagher, and M. Karin (2008)
Science 321, 663-668
   Abstract »    Full Text »    PDF »
Epstein-Barr Virus Latent Membrane Protein 1 Induces Expression of the Epidermal Growth Factor Receptor through Effects on Bcl-3 and STAT3.
C.-P. Kung and N. Raab-Traub (2008)
J. Virol. 82, 5486-5493
   Abstract »    Full Text »    PDF »
Salmonella Secreted Factor L Deubiquitinase of Salmonella typhimurium Inhibits NF-{kappa}B, Suppresses I{kappa}B{alpha} Ubiquitination and Modulates Innate Immune Responses.
G. Le Negrate, B. Faustin, K. Welsh, M. Loeffler, M. Krajewska, P. Hasegawa, S. Mukherjee, K. Orth, S. Krajewski, A. Godzik, et al. (2008)
J. Immunol. 180, 5045-5056
   Abstract »    Full Text »    PDF »
JAB1 Determines the Response of Rheumatoid Arthritis Synovial Fibroblasts to Tumor Necrosis Factor-{alpha}.
J. Wang, C. Li, Y. Liu, W. Mei, S. Yu, C. Liu, L. Zhang, X. Cao, R. P. Kimberly, W. Grizzle, et al. (2006)
Am. J. Pathol. 169, 889-902
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882